Baishi Meishi Guibao's US stock rose more than 5% before trading
凉亭之中净
发表于 2024-9-27 17:21:01
1188
0
0
On September 27th, the US stock market of Bristol Myers Squibb rose more than 5% before trading, as US regulatory authorities approved its Cobenfy for the treatment of schizophrenia, the first drug approved for the treatment of schizophrenia in decades.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- JD's US stock market fell nearly 7% before trading
- The US stock market suffered a "black door" in September, with Nvidia evaporating nearly 2 trillion yuan overnight, creating the largest daily market value loss in US stock history
- Baishi Meishi Guibao's US stock rose more than 5% before trading
- Jiaxin Wealth Management's US stock market rose nearly 8% before trading
- Top 20 US stock transactions: ASML's performance hits rock bottom, leading to collapse of US chip stocks
- The US stock market is about to undergo significant changes. The New York Stock Exchange has announced an extension of trading hours!
- ULTRA beauty stocks rose over 11% before trading
- Investment Strategy for US Stocks in 2025: Re inflation Risk Restarting, US Stocks Rise and Fall
